Probability of Treatment Following Acute Drop in Lung Function in Children with Cystic Fibrosis is related to baseline pulmonary function

Lignende værker

• Clinical Use of Dornase Alfa Is Associated with a Slower Rate of FEV(1) Decline in Cystic Fibrosis
  af: Konstan, Michael W., et al.
  Udgivet: (2011)
• Clinical Use of Tobramycin Inhalation Solution (TOBI(®)) Shows Sustained Improvement in FEV1 in Cystic Fibrosis
  af: Konstan, Michael W., et al.
  Udgivet: (2013)
• Socioeconomic Status and the Likelihood of Antibiotic Treatment for Signs and Symptoms of Pulmonary Exacerbation in Children with Cystic Fibrosis
  af: Schechter, Michael S., et al.
  Udgivet: (2011)
• Trends in the Use of Routine Therapies in Cystic Fibrosis: 1995–2005
  af: Konstan, Michael W., et al.
  Udgivet: (2010)
• RISK FACTORS FOR RATE OF DECLINE IN FEV(1) IN ADULTS WITH CYSTIC FIBROSIS
  af: Konstan, Michael W., et al.
  Udgivet: (2012)